日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dyr726, a brain-penetrant inhibitor of PI3Kα, Type III receptor tyrosine kinases, and WNT signaling.

Dyr726 是一种可穿透血脑屏障的 PI3Kα、III 型受体酪氨酸激酶和 WNT 信号通路抑制剂

Tandon Vasudha, Fistrovich Alessandra, Nogales Joaquina, Ferro Febe, Rokey Samantha N, Cabel Carly, Miller Amy Dunne, Yagel Mary, Duncan Christina, Atmasidha Aditi, Sharma Ira, Wilms Gerrit, Williams Karin, Elliott Richard, Chavez Timothy, Shaw Yeng, McMahon Aidan, Ginn Sean, Basantes L Emilia, Bedard Nathan, Gokhale Vijay, Ellis Nathan, Prescott Alan R, Smith Stuart J, Rahman Ruman, Becker Walter, Read Kevin D, Chalmers Anthony J, Carragher Neil, Masson Glenn R, Montfort William, Thorne Curtis, Hulme Christopher, Banerjee Sourav

UA62784, a novel inhibitor of centromere protein E kinesin-like protein

UA62784,一种新型着丝粒蛋白E驱动蛋白样蛋白抑制剂

Henderson, Meredith C; Shaw, Yeng-Jeng Y; Wang, Hong; Han, Haiyong; Hurley, Laurence H; Flynn, Gary; Dorr, Robert T; Von Hoff, Daniel D

Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity.

新型喹唑啉类化合物通过靶向肿瘤血管生成来抑制前列腺肿瘤的发生

Garrison Jason B, Shaw Yeng-Jeng, Chen Ching-Shih, Kyprianou Natasha